Patents-Review.com
πŸ”— Permalink
Assignee profile:

ASTELLAS PHARMA INC.

City:

Tokyo

Country:

Japan

Published Applications:

490

Last publication date:

2026-03-26

Patent Grants:

377

Last grant date:

2026-01-13

Quarterly ASTELLAS PHARMA INC. Patent Applications

Top Inventors for applications by ASTELLAS PHARMA INC.

These are the the leading inventors for applications assigned to ASTELLAS PHARMA INC.:

Recent patent applications by ASTELLAS PHARMA INC.

ASTELLAS PHARMA INC. based in Tokyo, JP has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2026-03-26
US20260083677A1
Human necessities

ACTIVE INGREDIENT CONTAINING STABILISED SOLID MEDICINAL FORMS AND METHODS FOR THE PRODUCTION THEREOF

 #2 | 2026-02-12
US20260042771A1
Chemistry; metallurgy

HETEROCYCLIC COMPOUND FOR INDUCING DEGRADATION OF G12V MUTANT KRAS PROTEIN

 #3 | 2025-12-25
US20250388569A1
Chemistry; metallurgy

HETEROCYCLIC COMPOUND FOR INHIBITING AND/OR INDUCING DEGRADATION OF KRAS PROTEIN

 #4 | 2025-10-09
US20250312471A1
Human necessities

ANTIBODY-DRUG COMPLEX CONTAINING TOLL-LIKE RECEPTOR 7/8 DUAL AGONIST COMPOUND

 #5 | 2025-06-05
US20250177603A1
Human necessities

THROMBIN-CARRYING HEMOSTATIC SHEET

 #6 | 2025-05-22 βœ… Patent 12,522,593 granted on 2026-01-13
US20250163041A1
Chemistry; metallurgy

AZACYCLOALKYL CARBONYL CYCLIC AMINE COMPOUND

 #7 | 2025-05-15
US20250154272A1
Chemistry; metallurgy

ANTI-CLDN4/ANTI-CD137 BISPECIFIC ANTIBODY

 #8 | 2025-03-20 βœ… Patent 12,502,357 granted on 2025-12-23
US20250090465A1
Human necessities

Formulations of Enzalutamide

 #9 | 2025-03-13
US20250084062A1
Chemistry; metallurgy

SUBSTITUTED QUINOLINE DERIVATIVE

 #10 | 2025-01-23 βœ… Patent 12,390,536 granted on 2025-08-19
US20250025567A1
Human necessities

ANTIBODY-DRUG COMPLEX CONTAINING TOLL-LIKE RECEPTOR 7/8 DUAL AGONIST COMPOUND

 #11 | 2024-09-26 βœ… Patent 12,559,522 granted on 2026-02-24
US20240317804A1
Chemistry; metallurgy

CELL PENETRATING PEPTIDE

 #12 | 2024-09-24 βœ… Patent 12,097,189 granted on 2024-09-24
US18613281
Human necessities

Pharmaceutical composition for modified release

 #13 | 2024-06-27 βœ… Patent 12,227,586 granted on 2025-02-18
US20240209108A1
Chemistry; metallurgy

Anti-CLDN4/anti-CD137 bispecific antibody

 #14 | 2024-06-06 βœ… Patent 12,384,794 granted on 2025-08-12
US20240182483A1
Chemistry; metallurgy

QUINAZOLINE COMPOUND FOR INDUCING DEGRADATION OF G12D MUTANT KRAS PROTEIN

 #15 | 2024-06-06
US20240180906A1
Human necessities

Combination of Talazoparib and an Anti-Androgen for the Treatment of DDR Gene Mutated Metastatic Castration-Sensitive Prostate Cancer

 #16 | 2024-05-23 βœ… Patent 12,304,951 granted on 2025-05-20
US20240166736A1
Chemistry; metallurgy

Anti-TSPAN8/anti-CD3 bispecific antibody and anti-TSPAN8 antibody

 #17 | 2024-05-23
US20240164692A1
Human necessities

ELECTROCARDIOGRAM ANALYSIS ASSISTANCE DEVICE, PROGRAM, ELECTROCARDIOGRAM ANALYSIS ASSISTANCE METHOD, ELECTROCARDIOGRAM ANALYSIS ASSISTANCE SYSTEM, PEAK ESTIMATION MODEL GENERATION METHOD, AND SEGMENT ESTIMATION MODEL GENERATION METHOD

 #18 | 2024-05-23
US20240164691A1
Human necessities

ELECTROCARDIOGRAM ANALYSIS ASSISTANCE DEVICE, PROGRAM, ELECTROCARDIOGRAM ANALYSIS ASSISTANCE METHOD, AND ELECTROCARDIOGRAM ANALYSIS ASSISTANCE SYSTEM

 #19 | 2024-05-02
US20240138690A1
Human necessities

ARRHYTHMIC STATE DETECTION ASSISTING DEVICE AND PROGRAM

 #20 | 2024-04-04 βœ… Patent 12,188,097 granted on 2025-01-07
US20240110247A1
Chemistry; metallurgy

Methods and compositions for prediction of therapeutic efficacy of cancer treatments and cancer prognosis

 #21 | 2024-03-28 βœ… Patent 12,077,519 granted on 2024-09-03
US20240101532A1
Chemistry; metallurgy

Heteroaryl carboxamide compound

 #22 | 2024-02-08 βœ… Patent 12,655,122 granted on 2026-06-16
US20240043403A1
Chemistry; metallurgy

HETEROARYL CARBOXAMIDE COMPOUND

 #23 | 2024-01-18 βœ… Patent 11,912,679 granted on 2024-02-27
US20240018113A1
Chemistry; metallurgy

Aryl alkynamide derivatives

 #24 | 2024-01-04
US20240000783A1
Human necessities

COMBINATION THERAPY

 #25 | 2023-11-30
US20230381305A1
Human necessities

METHOD FOR TREATING CANCER USING ARTIFICIAL ADJUVANT CELL (aAVC)

 #26 | 2023-11-02 βœ… Patent 11,897,954 granted on 2024-02-13
US20230348587A1
Chemistry; metallurgy

Anti-TSPAN8/anti-CD3 bispecific antibody and anti-TSPAN8 antibody

 #27 | 2023-09-28 βœ… Patent 11,938,130 granted on 2024-03-26
US20230301992A1
Human necessities

Stable pharmaceutical composition for oral administration

 #28 | 2023-09-07 βœ… Patent 11,938,133 granted on 2024-03-26
US20230277532A1
Human necessities

Stable pharmaceutical composition for oral administration

 #29 | 2023-09-07 βœ… Patent 11,938,132 granted on 2024-03-26
US20230277531A1
Human necessities

Stable pharmaceutical composition for oral administration

 #30 | 2023-09-07 βœ… Patent 11,944,620 granted on 2024-04-02
US20230277530A1
Human necessities

Stable pharmaceutical composition for oral administration

 #31 | 2023-09-07 βœ… Patent 11,938,131 granted on 2024-03-26
US20230277529A1
Human necessities

Stable pharmaceutical composition for oral administration

 #32 | 2023-07-06 βœ… Patent 11,839,689 granted on 2023-12-12
US20230210778A1
Human necessities

Formulations of enzalutamide

 #33 | 2023-06-29 βœ… Patent 12,377,601 granted on 2025-08-05
US20230202096A1
Performing operations; transporting

FAST-ELUTING THREE-DIMENSIONALLY MOLDED OBJECT, FILAMENT FOR FAST-ELUTING THREE-DIMENSIONALLY MOLDED OBJECT, AND MATERIAL FOR FAST-ELUTING THREE-DIMENSIONALLY MOLDED OBJECT

 #34 | 2023-04-20 βœ… Patent 12,447,128 granted on 2025-10-21
US20230122911A1
Human necessities

FORMULATIONS OF ENZALUTAMIDE

 #35 | 2023-04-13
US20230113105A1
Human necessities

WEARABLE DEVICE, INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING SYSTEM, AND PROGRAM

 #36 | 2023-04-13
US20230111840A1
Chemistry; metallurgy

Compound, And Method For Producing Regulatory T Cells

 #37 | 2023-02-09 βœ… Patent 12,161,628 granted on 2024-12-10
US20230042959A1
Human necessities

Combination therapy

 #38 | 2023-01-05 βœ… Patent 11,672,851 granted on 2023-06-13
US20230000965A1
Human necessities

NY-ESO-1-containing artificial adjuvant vector cell for use in treatment of cancer

 #39 | 2022-12-01
US20220379171A1
Human necessities

EXERCISE SUPPORT DEVICE, EXERCISE SUPPORT SYSTEM, EXERCISE SUPPORT METHOD, AND PROGRAM

 #40 | 2022-11-10 βœ… Patent 12,018,095 granted on 2024-06-25
US20220356207A1
Chemistry; metallurgy

Cell penetrating peptide

 #41 | 2022-10-06 βœ… Patent 12,227,517 granted on 2025-02-18
US20220315603A1
Chemistry; metallurgy

Pyridazinyl-thiazolecarboxamide compound

 #42 | 2022-09-29 βœ… Patent 12,559,531 granted on 2026-02-24
US20220306711A1
Chemistry; metallurgy

CLAUDIN-6-SPECIFIC IMMUNORECEPTORS AND T CELL EPITOPES

 #43 | 2022-05-26 βœ… Patent 11,919,951 granted on 2024-03-05
US20220162302A1
Chemistry; metallurgy

Antibodies useful in cancer diagnosis

 #44 | 2022-05-19 βœ… Patent 12,178,814 granted on 2024-12-31
US20220152020A1
Human necessities

Pharmaceutical composition

 #45 | 2022-01-27 βœ… Patent 11,712,472 granted on 2023-08-01
US20220023422A1
Human necessities

Pharmaceutical composition comprising anti-human TSLP receptor antibody

 #46 | 2022-01-20 βœ… Patent 11,617,790 granted on 2023-04-04
US20220016239A1
Human necessities

Method for treating cancer using artificial adjuvant cell (aAVC)

 #47 | 2021-12-16 βœ… Patent 12,209,134 granted on 2025-01-28
US20210388096A1
Chemistry; metallurgy

Anti-human Fn14 antibody

 #48 | 2021-11-18 βœ… Patent 11,473,071 granted on 2022-10-18
US20210355464A1
Chemistry; metallurgy

Method for treating muscular dystrophy by targeting utrophin gene

 #49 | 2021-11-18 βœ… Patent 12,065,503 granted on 2024-08-20
US20210355233A1
Chemistry; metallurgy

Pharmaceutical composition containing tagged site-antihuman antibody fab fragment complex

 #50 | 2021-11-04 βœ… Patent 11,312,966 granted on 2022-04-26
US20210340549A1
Chemistry; metallurgy

Nucleic acid for treating mite allergy

 #51 | 2021-11-04 βœ… Patent 12,029,797 granted on 2024-07-09
US20210338845A1
Human necessities

Fatty acid derivative labeled with positron-emitting radionuclide

 #52 | 2021-10-21 βœ… Patent 11,732,308 granted on 2023-08-22
US20210324472A1
Chemistry; metallurgy

Methods and compositions for prediction of therapeutic efficacy of cancer treatments and cancer prognosis

 #53 | 2021-10-14 βœ… Patent 11,638,730 granted on 2023-05-02
US20210315951A1
Human necessities

Cancer therapy by combination use of oncolytic vaccinia virus and immune checkpoint inhibitor, and pharmaceutical composition and combination medicine for use in the cancer therapy

 #54 | 2021-09-23
US20210292853A1
Chemistry; metallurgy

DETECTION OF CLDN18-ARHGAP6 FUSION GENE OR CLDN18-ARHGAP26 FUSION GENE IN PANCREATIC CANCER

 #55 | 2021-09-23 βœ… Patent 11,925,638 granted on 2024-03-12
US20210290618A1
Human necessities

Pharmaceutical composition comprising diamino heterocyclic carboxamide compound as active ingredient

 #56 | 2021-06-03 βœ… Patent 11,414,456 granted on 2022-08-16
US20210163533A1
Chemistry; metallurgy

Cell penetrating peptide

 #57 | 2021-03-25 βœ… Patent 11,707,451 granted on 2023-07-25
US20210085654A1
Human necessities

Pharmaceutical composition for modified release

 #58 | 2021-01-28 βœ… Patent 11,826,402 granted on 2023-11-28
US20210023177A1
Human necessities

Combination therapy involving antibodies against claudin 18.2 for treatment of metastatic pancreatic adenocarcinoma

 #59 | 2020-12-31 βœ… Patent 11,746,332 granted on 2023-09-05
US20200407692A1
Chemistry; metallurgy

Method for producing renal progenitor cells

 #60 | 2020-12-17 βœ… Patent 12,059,464 granted on 2024-08-13
US20200390887A1
Human necessities

Combination therapy involving antibodies against Claudin 18.2 for treatment of cancer

 #61 | 2020-12-10 βœ… Patent 11,795,218 granted on 2023-10-24
US20200385460A1
Chemistry; metallurgy

Diagnosis and therapy of cancer involving cancer stem cells

 #62 | 2020-12-10 βœ… Patent 11,739,139 granted on 2023-08-29
US20200385448A1
Chemistry; metallurgy

Monoclonal antibodies against Claudin-18 for treatment of cancer

 #63 | 2020-10-29
US20200338149A1
Human necessities

NOVEL GENETICALLY ENGINEERED VACCINIA VIRUSES

 #64 | 2020-09-17 βœ… Patent 11,344,589 granted on 2022-05-31
US20200289592A1
Human necessities

Genetically engineered vaccinia viruses

 #65 | 2020-08-27 βœ… Patent 11,479,561 granted on 2022-10-25
US20200270266A1
Chemistry; metallurgy

Tetrahydroisoquinoline derivatives

 #66 | 2020-06-25 βœ… Patent 11,279,757 granted on 2022-03-22
US20200199221A1
Chemistry; metallurgy

Antibodies useful in cancer diagnosis

 #67 | 2020-06-04
US20200171174A1
Human necessities

NOVEL ANTI-HUMAN MUC1 ANTIBODY FAB FRAGMENT

 #68 | 2020-05-14 βœ… Patent 12,036,315 granted on 2024-07-16
US20200146977A1
Human necessities

Pharmaceutical composition for oral administration comprising enzalutamide

 #69 | 2020-05-07 βœ… Patent 10,774,082 granted on 2020-09-15
US20200140437A1
Chemistry; metallurgy

Quinazoline compound

 #70 | 2020-05-07 βœ… Patent 11,376,328 granted on 2022-07-05
US20200138957A1
Human necessities

Pharmaceutical composition

 #71 | 2020-04-23 βœ… Patent 11,667,724 granted on 2023-06-06
US20200123270A1
Chemistry; metallurgy

Anti-human CEACAM5 antibody Fab fragment

 #72 | 2020-03-05 βœ… Patent 11,180,554 granted on 2021-11-23
US20200071404A1
Chemistry; metallurgy

Anti-human CD73 antibody

 #73 | 2020-02-20 βœ… Patent 10,975,091 granted on 2021-04-13
US20200055868A1
Chemistry; metallurgy

Pyridine derivative

 #74 | 2019-12-19 βœ… Patent 11,578,067 granted on 2023-02-14
US20190382403A1
Chemistry; metallurgy

Compound, and method for producing regulatory T cells

 #75 | 2019-11-07
US20190336552A1
Human necessities

GENETICALLY ENGINEERED VACCINIA VIRUSES

 #76 | 2019-10-31 βœ… Patent 11,390,652 granted on 2022-07-19
US20190330280A1
Chemistry; metallurgy

Transcriptional regulatory fusion polypeptide

 #77 | 2019-10-10 βœ… Patent 11,787,862 granted on 2023-10-17
US20190309067A1
Chemistry; metallurgy

Bispecific trivalent antibodies binding to Claudin6 or Claudin18.2 and CD3 for treatment of Claudin expressing cancer diseases

 #78 | 2019-10-10 βœ… Patent 11,059,889 granted on 2021-07-13
US20190309063A1
Chemistry; metallurgy

Anti-human IgΞ² antibody

 #79 | 2019-10-03 βœ… Patent 10,946,069 granted on 2021-03-16
US20190298803A1
Human necessities

Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic cancer

 #80 | 2019-09-26 βœ… Patent 10,556,906 granted on 2020-02-11
US20190292182A1
Chemistry; metallurgy

Quinazoline compound

 #81 | 2019-09-05 βœ… Patent 10,507,251 granted on 2019-12-17
US20190269804A1
Human necessities

Anti-human MUC1 antibody fab fragment

 #82 | 2019-08-15 βœ… Patent 11,046,770 granted on 2021-06-29
US20190248904A1
Chemistry; metallurgy

Anti-human BDCA-2 antibody

 #83 | 2019-07-18 βœ… Patent 11,053,553 granted on 2021-07-06
US20190218620A1
Chemistry; metallurgy

Detection of CLDN18-ARHGAP6 fusion gene or CLDN18-ARHGAP26 fusion gene in pancreatic cancer

 #84 | 2019-07-18
US20190217531A1
Performing operations; transporting

FAST-ELUTING THREE-DIMENSIONALLY MOLDED OBJECT, FILAMENT FOR FAST-ELUTING THREE-DIMENSIONALLY MOLDED OBJECT, AND MATERIAL FOR FAST-ELUTING THREE-DIMENSIONALLY MOLDED OBJECT

 #85 | 2019-06-27 βœ… Patent 10,689,393 granted on 2020-06-23
US20190194220A1
Chemistry; metallurgy

Tetrahydroisoquinoline derivatives

 #86 | 2019-03-14 βœ… Patent 11,395,852 granted on 2022-07-26
US20190076525A1
Human necessities

Therapy involving antibodies against Claudin 18.2 for treatment of cancer

 #87 | 2019-03-14
US20190076365A1
Human necessities

TABLET

 #88 | 2018-11-15 βœ… Patent 10,421,762 granted on 2019-09-24
US20180327418A1
Chemistry; metallurgy

Pyridine derivative

 #89 | 2018-11-15 βœ… Patent 10,813,996 granted on 2020-10-27
US20180326059A1
Human necessities

Combination therapy involving antibodies against Claudin 18.2 for treatment of cancer

 #90 | 2018-09-27 βœ… Patent 10,731,133 granted on 2020-08-04
US20180273905A1
Chemistry; metallurgy

Method for producing renal progenitor cells

 #91 | 2018-09-06 βœ… Patent 10,619,216 granted on 2020-04-14
US20180251850A1
Chemistry; metallurgy

Method for detecting RP2-ARHGAP6 gene

 #92 | 2018-08-23 βœ… Patent 10,619,184 granted on 2020-04-14
US20180237862A1
Chemistry; metallurgy

Method for detecting OCLN-ARHGAP26 gene

 #93 | 2018-07-05 βœ… Patent 10,786,500 granted on 2020-09-29
US20180185359A1
Human necessities

Stable pharmaceutical composition for oral administration

 #94 | 2018-06-07 βœ… Patent 11,286,459 granted on 2022-03-29
US20180155676A1
Chemistry; metallurgy

Cell culturing method using nucleic acid-containing medium

 #95 | 2018-05-31 βœ… Patent 10,259,821 granted on 2019-04-16
US20180148458A1
Chemistry; metallurgy

Tetrahydroisoquinoline derivatives

 #96 | 2018-05-31 βœ… Patent 10,118,899 granted on 2018-11-06
US20180148417A1
Chemistry; metallurgy

Production method of enzalutamide crystal form

 #97 | 2018-05-17 βœ… Patent 10,188,737 granted on 2019-01-29
US20180133325A1
Human necessities

Stabilized pharmaceutical composition

 #98 | 2018-05-10 βœ… Patent 10,738,108 granted on 2020-08-11
US20180127489A1
Chemistry; metallurgy

Monoclonal antibodies against claudin-18 for treatment of cancer

 #99 | 2018-05-03 βœ… Patent 11,541,127 granted on 2023-01-03
US20180117174A1
Human necessities

Drug conjugates comprising antibodies against claudin 18.2

 #100 | 2018-05-03 βœ… Patent 10,548,845 granted on 2020-02-04
US20180116965A1
Human necessities

Pharmaceutical composition for oral administration

Also check out ASTELLAS PHARMA INC.'s (Tokyo, Japan) applicant profile with 143 patent applications submitted.

AssigneeID:

3671 ⎘